A detailed history of Drive Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Drive Wealth Management, LLC holds 8,696 shares of BMY stock, worth $502,280. This represents 0.12% of its overall portfolio holdings.

Number of Shares
8,696
Previous 8,696 -0.0%
Holding current value
$502,280
Previous $450,000 -0.0%
% of portfolio
0.12%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $81,699 - $106,605
2,060 Added 31.04%
8,696 $450,000
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $78,044 - $102,747
-1,939 Reduced 22.61%
6,636 $275,000
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $15,929 - $18,060
332 Added 4.03%
8,575 $465,000
Q4 2023

Jan 22, 2024

BUY
$48.48 - $57.85 $727 - $867
15 Added 0.18%
8,243 $422,000
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $96,271 - $107,645
1,663 Added 25.33%
8,228 $477,000
Q2 2023

Jul 14, 2023

SELL
$63.71 - $70.74 $111,365 - $123,653
-1,748 Reduced 21.03%
6,565 $419,000
Q1 2023

Apr 13, 2023

BUY
$65.71 - $74.53 $53,290 - $60,443
811 Added 10.81%
8,313 $576,000
Q4 2022

Jan 27, 2023

BUY
$68.48 - $81.09 $101,966 - $120,743
1,489 Added 24.76%
7,502 $0
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $95 - $56,631
-737 Reduced 10.92%
6,013 $427,000
Q2 2022

Nov 14, 2022

BUY
$72.62 - $79.98 $70,296 - $77,420
968 Added 16.74%
6,750 $523,000
Q1 2022

Nov 14, 2022

SELL
$61.48 - $73.72 $373,921 - $448,365
-6,082 Reduced 51.26%
5,782 $425,000
Q4 2021

Nov 14, 2022

BUY
$53.63 - $62.52 $636,266 - $741,737
11,864 New
11,864 $740,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Drive Wealth Management, LLC Portfolio

Follow Drive Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drive Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drive Wealth Management, LLC with notifications on news.